Skip to main content
. 2015 Jun 15;5:11348. doi: 10.1038/srep11348

Figure 4. Begg’s funnel plots of BIM deletion polymorphism and response rate, disease control rate and progression-free survival in malignancy with kinase inhibitor therapy.

Figure 4

(A) BIM deletion polymorphism and response rate; (B) BIM deletion polymorphism and disease control rate; (C) BIM deletion polymorphism and progression-free survival.